Axillary artery cannulation for veno-arterial extracorporeal membrane oxygenation support in cardiogenic shock.

Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.

Mineralocorticoid Receptor Antagonist Use in Heart Failure With Reduced Ejection Fraction and End-Stage Renal Disease Patients on Dialysis: A Literature Review.

Pluripotent hematopoietic stem cells augment Îą-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension.

Cardiogenic shock during heart failure hospitalizations: Age-, sex-, and race-stratified trends in incidence and outcomes.

Novel drug therapies for cardiac amyloidosis.

Role of Advanced Testing: Invasive Hemodynamics, Endomyocardial Biopsy, and Cardiopulmonary Exercise Testing.

Diagnosis, Treatment, and Management of Orthotopic Liver Transplant Candidates With Portopulmonary Hypertension.

Chronic Thromboembolic Pulmonary Hypertension: Epidemiology, Diagnosis, and Management.

Newer hormonal pharmacotherapies for heart failure.

Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation.

Left Ventricular Assist Device in Older Adults.

Update on pulmonary arterial hypertension pharmacotherapy.

Usefulness of a standard automated blood pressure monitor in patients with continuous-flow left ventricular assist devices.

New Insights and Clarity for Peripartum Heart Failure and Recovery in the Modern Era.